Trotana Therapeutics Funding: $53M Raised, Series A (2025)
Trotana Therapeutics is based in San Diego, California. It has raised $53M in total funding. Latest round: Series A.
Trotana Therapeutics funding overview
Trotana Therapeutics is based in San Diego, California. Trotana Therapeutics has raised $53M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2025. The round record for Trotana Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Canaan Partners, Lightstone Ventures. 2 distinct backers are named across the disclosed rounds.
Trotana Therapeutics at a glance
Total raised
$53M
Latest round
Series A
Latest round date
January 2025
Headquarters
San Diego, California
Notable investors
Canaan Partners, Lightstone Ventures
Frequently asked about Trotana Therapeutics funding
How much has Trotana Therapeutics raised?
Trotana Therapeutics has raised $53M in total disclosed funding across the rounds on record.
Who has invested in Trotana Therapeutics?
Canaan Partners, Lightstone Ventures are named among the investors backing Trotana Therapeutics.
What was the latest Trotana Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2025.
Where is Trotana Therapeutics based?
Trotana Therapeutics is based in San Diego, California.
When did Trotana Therapeutics last raise?
The last disclosed Trotana Therapeutics round closed in January 2025 at Series A.
Round data for Trotana Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Diego and backer lists below.
